Galane Gold Ltd. Releases Financial and Operating Results for Q1 2020
TORONTO, May 22, 2020 (GLOBE NEWSWIRE) — Galane Gold Ltd. (“Galane Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) is […]
Harsco to Participate in KeyBanc Capital Markets’ Industrials & Basic Materials Virtual Conference
CAMP HILL, Pa., May 22, 2020 (GLOBE NEWSWIRE) — Harsco Corporation (NYSE: HSC) announced today that Company management will present […]
Daxor’s BVA-100® Published in Novel Study in American Heart Association Journal – Circulation
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation […]
Ryman Hospitality Properties, Inc. Announces Termination of Agreement to Purchase the Block 21 Complex in Austin, Texas
NASHVILLE, Tenn., May 22, 2020 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) today announced the termination […]
Legend Power® Schedules Q2 2020 Financial Results Release and Conference Call
VANCOUVER, British Columbia, May 22, 2020 (GLOBE NEWSWIRE) — Legend Power® Systems Inc. (TSX.V: LPS) (“Legend Power” or the “Company”), […]
VitalHub Announces Sale of DOCit Mobile Application to Another Municipally-Operated Long-Term Care Facility – Initial Phase of Deployment to Begin With Rollout of COVID-19 Screening Solution
TORONTO, May 22, 2020 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce the […]
NexTech’s New 3D/AR Ad Network Increases Sales Conversions by 300% for Company’s E-commerce Site
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an emerging […]
Teligent, Inc. Announces First Quarter 2020 Results
BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today […]
Zynerba Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
DEVON, Pa., May 22, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]
Harpoon Therapeutics to Present Interim Clinical Data for TriTAC® HPN424 at the ASCO20 Virtual Scientific Program
SOUTH SAN FRANCISCO, Calif., May 22, 2020 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing […]
